Page last updated: 2024-11-02

pinacidil and Hypokalemic Periodic Paralysis

pinacidil has been researched along with Hypokalemic Periodic Paralysis in 1 studies

Pinacidil: A guanidine that opens POTASSIUM CHANNELS producing direct peripheral vasodilatation of the ARTERIOLES. It reduces BLOOD PRESSURE and peripheral resistance and produces fluid retention. (Martindale The Extra Pharmacopoeia, 31st ed)

Hypokalemic Periodic Paralysis: An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)

Research Excerpts

ExcerptRelevanceReference
" In one study dichlorphenamide (DCP) vs placebo was tested in two groups of participants: 42 with hypokalemic periodic paralysis (HypoPP) and 31 with hyperkalemic periodic paralysis (HyperPP), based on clinical criteria."4.84Treatment for periodic paralysis. ( Links, TP; Meola, G; Panzeri, M; Rose, MR; Sansone, V, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sansone, V1
Meola, G1
Links, TP1
Panzeri, M1
Rose, MR1

Reviews

1 review available for pinacidil and Hypokalemic Periodic Paralysis

ArticleYear
Treatment for periodic paralysis.
    The Cochrane database of systematic reviews, 2008, Jan-23, Issue:1

    Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Dichlorphenamide; Humans; Hypokalemic Periodic Paralys

2008